These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9154976)

  • 1. Preparation and anti-HIV activity of N-3-substituted thymidine nucleoside analogs.
    Adams DR; Perez C; Maillard M; Florent JC; Evers M; Hénin Y; Litvak S; Litvak L; Monneret C; Grierson DS
    J Med Chem; 1997 May; 40(10):1550-8. PubMed ID: 9154976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
    Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
    J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
    Velázquez S; Chamorro C; Pérez-Pérez MJ; Alvarez R; Jimeno ML; Martín-Domenech A; Pérez C; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
    J Med Chem; 1998 Nov; 41(23):4636-47. PubMed ID: 9804703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anti-HIV activity of 4'-substituted 4'-thiothymidines: a new entry based on nucleophilic substitution of the 4'-acetoxy group.
    Haraguchi K; Shimada H; Tanaka H; Hamasaki T; Baba M; Gullen EA; Dutschman GE; Cheng YC
    J Med Chem; 2008 Mar; 51(6):1885-93. PubMed ID: 18311897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, anti-HIV activity, and resistance profile of thymidine phosphonomethoxy nucleosides and their bis-isopropyloxymethylcarbonyl (bisPOC) prodrugs.
    Mackman RL; Zhang L; Prasad V; Boojamra CG; Douglas J; Grant D; Hui H; Kim CU; Laflamme G; Parrish J; Stoycheva AD; Swaminathan S; Wang K; Cihlar T
    Bioorg Med Chem; 2007 Aug; 15(16):5519-28. PubMed ID: 17562366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of novel thymidine analogs as antitumor and antiviral agents.
    Chen X; Bastow K; Goz B; Kucera LS; Morris-Natschke SL; Ishaq KS
    J Med Chem; 1996 Aug; 39(17):3412-7. PubMed ID: 8765526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the mechanism of action and decomposition of amino acid phosphomonoester amidates of antiviral nucleoside prodrugs.
    McIntee EJ; Remmel RP; Schinazi RF; Abraham TW; Wagner CR
    J Med Chem; 1997 Oct; 40(21):3323-31. PubMed ID: 9341906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nucleoside analogs 4'C-methyl thymidine and 4'C-ethyl thymidine block DNA synthesis by wild-type HIV-1 RT and excision proficient NRTI resistant RT variants.
    Boyer PL; Julias JG; Ambrose Z; Siddiqui MA; Marquez VE; Hughes SH
    J Mol Biol; 2007 Aug; 371(4):873-82. PubMed ID: 17597154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]- 3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2" -dioxide) derivatives with anti-HIV-1 and anti-human-cytomegalovirus activity.
    de Castro S; Lobatón E; Pérez-Pérez MJ; San-Félix A; Cordeiro A; Andrei G; Snoeck R; De Clercq E; Balzarini J; Camarasa MJ; Velázquez S
    J Med Chem; 2005 Feb; 48(4):1158-68. PubMed ID: 15715482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and HIV inhibition activity of 2',3'-dideoxy-3'-C-hydroxymethyl nucleosides.
    Lee-Ruff E; Ostrowski M; Ladha A; Stynes DV; Vernik I; Jiang JL; Wan WQ; Ding SF; Joshi S
    J Med Chem; 1996 Dec; 39(26):5276-80. PubMed ID: 8978856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSAO-T analogues bearing amino acids at position N-3 of thymine: synthesis and anti-human immunodeficiency virus activity.
    Chamorro C; De Clercq E; Balzarini J; Camarasa MJ; San-Félix A
    Antivir Chem Chemother; 2000 Jan; 11(1):61-9. PubMed ID: 10693655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the antiviral efficacy and selectivity of HIV-1 reverse transcriptase inhibitor TSAO-T by the introduction of functional groups at the N-3 position.
    Bonache MC; Chamorro C; Velázquez S; De Clercq E; Balzarini J; Barrios FR; Gago F; Camarasa MJ; San-Félix A
    J Med Chem; 2005 Oct; 48(21):6653-60. PubMed ID: 16220981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anti-HIV activity of novel N-1 side chain-modified analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).
    Pontikis R; Benhida R; Aubertin AM; Grierson DS; Monneret C
    J Med Chem; 1997 Jun; 40(12):1845-54. PubMed ID: 9191961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    Chamorro C; Camarasa MJ; Pérez-Pérez MJ; de Clercq E; Balzarini J; San Félix A
    Antivir Chem Chemother; 1998 Sep; 9(5):413-22. PubMed ID: 9875394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-acyl-2-thioethyl phosphoramidate diester derivatives as mononucleotide prodrugs.
    Egron D; Imbach JL; Gosselin G; Aubertin AM; Périgaud C
    J Med Chem; 2003 Oct; 46(21):4564-71. PubMed ID: 14521418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anti-HIV activity evaluation of novel 2,4-disubstituted 7-methyl-1,1,3-trioxo-2,4-dihydro-pyrazolo-[4,5-e][1,2]thiadiazines.
    Liu XY; Yan RZ; Wang Y; Zhan P; De Clercq E; Pannecouque C; Witvrouw M; Molina MT; Vega S
    Arch Pharm (Weinheim); 2008 Apr; 341(4):216-22. PubMed ID: 18266290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of TSAO derivatives with an unusual HIV-1 activity/resistance profile.
    de Castro S; García-Aparicio C; Van Laethem K; Gago F; Lobatón E; De Clercq E; Balzarini J; Camarasa MJ; Velázquez S
    Antiviral Res; 2006 Aug; 71(1):15-23. PubMed ID: 16616962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents.
    Sun IC; Wang HK; Kashiwada Y; Shen JK; Cosentino LM; Chen CH; Yang LM; Lee KH
    J Med Chem; 1998 Nov; 41(23):4648-57. PubMed ID: 9804704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First synthesis and evaluation of the inhibitory effects of aza analogues of TSAO on HIV-1 replication.
    Nguyen Van Nhien A; Tomassi C; Len C; Marco-Contelles JL; Balzarini J; Pannecouque C; De Clercq E; Postel D
    J Med Chem; 2005 Jun; 48(13):4276-84. PubMed ID: 15974581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiviral activity of C-5 substituted beta-D- and beta-L-D4T analogues.
    Delbederi Z; Fossey C; Fontaine G; Benzaria S; Gavriliu D; Ciurea A; Lelong B; Ladurée D; Aubertin AM; Kirn A
    Nucleosides Nucleotides Nucleic Acids; 2000 Sep; 19(9):1441-61. PubMed ID: 11092314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.